Related references
Note: Only part of the references are listed.Impact of Insulin Tregopil and Its Permeation Enhancer on Pharmacokinetics of Metformin in Healthy Volunteers: Randomized, Open-Label, Placebo-Controlled, Crossover Study
Anand Khedkar et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial
Stephen C. Bain et al.
DIABETES OBESITY & METABOLISM (2019)
Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
Inge B. Halberg et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
Charlotte Granhall et al.
CLINICAL PHARMACOKINETICS (2018)
A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide
Tine A. Baekdal et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Human gut microbiome: hopes, threats and promises
Patrice D. Cani
GUT (2018)
Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae
Sam Maher et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
Tine A. Baekdal et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Oral delivery of anti-diabetes therapeutics using cell penetrating and transcytosing peptide strategies
Sahrish Rehmani et al.
PEPTIDES (2018)
Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
Stephen T. Buckley et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Re-evaluation of sodium, potassium and calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) as food additives
Maged Younes et al.
EFSA JOURNAL (2018)
Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes A Randomized Clinical Trial
Melanie Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
THPdb: Database of FDA-approved peptide and protein therapeutics
Salman Sadullah Usmani et al.
PLOS ONE (2017)
Intestinal patch systems for oral drug delivery
Amrita Banerjee et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Oral delivery of diabetes peptides - Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context
Harivardhan Reddy Lakkidreddy et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials
T. A. S. Aguirre et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Intestinal permeation enhancers for oral peptide delivery
Sam Maher et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D
Kim Henriksen et al.
BONE (2016)
Human Intestinal Barrier Function in Health and Disease
Julia Konig et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Safety concerns over the use of intestinal permeation enhancers: A mini-review
Fiona McCartney et al.
TISSUE BARRIERS (2016)
Peptide therapeutics: current status and future directions
Keld Fosgerau et al.
DRUG DISCOVERY TODAY (2015)
Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol
David J. Brayden et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Interaction with Mixed Micelles in the Intestine Attenuates the Permeation Enhancing Potential of Alkyl-Maltosides
Kerstin Gradauer et al.
MOLECULAR PHARMACEUTICS (2015)
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
Benoit Chassaing et al.
NATURE (2015)
Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials
M. A. Karsdal et al.
OSTEOARTHRITIS AND CARTILAGE (2015)
Challenges in the delivery of peptide drugs: an industry perspective
Andrew L. Lewis et al.
THERAPEUTIC DELIVERY (2015)
A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules
Bibi F. Choonara et al.
BIOTECHNOLOGY ADVANCES (2014)
A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells
David J. Brayden et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Acute Binge Drinking Increases Serum Endotoxin and Bacterial DNA Levels in Healthy Individuals
Shashi Bala et al.
PLOS ONE (2014)
Formulation strategies to improve oral peptide delivery
Sam Maher et al.
PHARMACEUTICAL PATENT ANALYST (2014)
Sodium caprate as an enhancer of macromolecule permeation across tricellular tight junctions of intestinal cells
Susanne M. Krug et al.
BIOMATERIALS (2013)
Trends in drug delivery through tissue barriers containing tight junctions
Christian Tscheik et al.
TISSUE BARRIERS (2013)
Absorption Enhancers: Applications and Advances
Bruce J. Aungst
AAPS JOURNAL (2012)
A review of the efficacy and safety of nanoparticle-based oral insulin delivery systems
Jeffrey W. Card et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms
Chifu B. Huang et al.
ARCHIVES OF ORAL BIOLOGY (2011)
Pharmacokinetics of Oral Cyanocobalamin Formulated With Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): An Open-Label, Randomized, Single-Dose, Parallel-Group Study in Healthy Male Subjects
M. Cristina Castelli et al.
CLINICAL THERAPEUTICS (2011)
Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials
M. A. Karsdal et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET®)
Edwin G. Walsh et al.
THERAPEUTIC DELIVERY (2011)
Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
Christoph Kapitza et al.
DIABETES CARE (2010)
The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides
El-Sayed Khafagy et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate
Xuexuan Wang et al.
THERAPEUTIC DELIVERY (2010)
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic
Sam Maher et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Stem Cells, Self-Renewal, and Differentiation in the Intestinal Epithelium
Laurens G. van der Flier et al.
ANNUAL REVIEW OF PHYSIOLOGY (2009)
Oral administration of the GnRH antagonist acyline, in a GIPETA®-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics
John Kenneth Amory et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Displacement of tight junction proteins from detergent-resistant membrane domains by treatment with sodium caprate
Ko Sugibayashi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae
Sam Maher et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Subchronic Oral Toxicity of Salcaprozate Sodium (SNAC) in Sprague-Dawley and Wistar Rats
M. Gary I. Riley et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2009)
Peri- and Postnatal Developmental Toxicity of Salcaprozate Sodium (SNAC) in Sprague-Dawley Rats
M. Gary I. Riley et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2009)
The Drug Transporter-Metabolism Alliance: Uncovering and Defining the Interplay
Leslie Z. Benet
MOLECULAR PHARMACEUTICS (2009)
Gastric mucosal defense and cytoprotection: Bench to bedside
Loren Laine et al.
GASTROENTEROLOGY (2008)
Oral delivery of antisense oligonucleotides in man
Lloyd G. Tillman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Myosin light chain kinase inhibition:: Correction of increased intestinal epithelial permeability in vitro
Linda M. Feighery et al.
PHARMACEUTICAL RESEARCH (2008)
Safe and effective permeation enhancers for oral drug delivery
Kathryn Whitehead et al.
PHARMACEUTICAL RESEARCH (2008)
Evaluation of mucosal damage and recovery in the gastrointestinal tract of rats by a penetration enhancer
Yogeeta Narkar et al.
PHARMACEUTICAL RESEARCH (2008)
In vitro interactions between the oral absorption promoter, sodium caprate (C-10) and S-Typhimurium in rat intestinal ileal mucosae
Alyssa B. Cox et al.
PHARMACEUTICAL RESEARCH (2008)
Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative
Adam W. G. Alani et al.
PHARMACEUTICAL RESEARCH (2008)
Pharmacokinefics and pharmalcodynamics of oral heparin solid dosage form in healthy human subjects
Shaker A. Mousa et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Restoration of barrier function in injured intestinal mucosa
Anthony T. Blikslager et al.
PHYSIOLOGICAL REVIEWS (2007)
Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method
S Hess et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Oral absorption enhancement of cromolyn sodium through noncovalent complexation
X Ding et al.
PHARMACEUTICAL RESEARCH (2004)
Medium-chain fatty acids decrease colonization and invasion through hilA suppression shortly after infection of chickens with Salmonella enterica serovar enteritidis
F Van Immerseel et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2004)
Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate
AA Raoof et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplasty
SD Berkowitz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Challenges for the oral delivery of macromolecules
M Goldberg et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
PG-mediated closure of paracellular pathway and not restitution is the primary determinant of barrier recovery in acutely injured porcine ileum
JL Gookin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs
AA Raoof et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers
T Buclin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate
D Malkov et al.
PHARMACEUTICAL RESEARCH (2002)
The influence of caprate on rectal absorption of phenoxymethylpenicillin:: experience from an in-vivo perfusion in humans
H Lennernäs et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Antifungal activities of pelargonic and capric acid on Microsporum gypseum
M Chadeganipour et al.
MYCOSES (2001)
Synchronized release of sulpiride and sodium decanoate from HPMC matrices: A rational approach to enhance sulpiride absorption in the rat intestine
M Baluom et al.
PHARMACEUTICAL RESEARCH (2000)
Share Paper
